{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:03:12Z","timestamp":1780581792451,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jpsychires.2014.02.010","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T16:09:04Z","timestamp":1393258144000},"page":"99-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China"],"prefix":"10.1016","volume":"53","author":[{"given":"Yao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alethea","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Schottenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek C.","family":"Chawarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2014.02.010_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1196\/annals.1369.012","article-title":"Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence","volume":"1074","author":"Akiyama","year":"2006","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1207\/S15327752JPA7503_02","article-title":"Prototypical profiles of the Brief Psychiatric Rating Scale","volume":"75","author":"Burger","year":"2000","journal-title":"J\u00a0Pers Assess"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A\u00a0review of clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway","year":"2006","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/10550490701861110","article-title":"Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up","volume":"17","author":"Glasner-Edwards","year":"2008","journal-title":"Am J Addict"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib7","first-page":"100","article-title":"Algorithm AS 136: a K-means clustering algorithm","volume":"28","author":"Hartigan","year":"1979","journal-title":"J\u00a0Roy Statist Soc Ser C (Applied Statist)"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present \u2013 a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib9","first-page":"48","article-title":"The Brief Psychiatric Rating Scale (BPRS): a comprehensive review","volume":"11","author":"Hedlund","year":"1980","journal-title":"J\u00a0Oper Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1176\/jnp.12.4.480","article-title":"Psychiatric comorbidity of methamphetamine dependence in a forensic sample","volume":"12","author":"Kalechstein","year":"2000","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib12","first-page":"1081","article-title":"Reliability and validity of using a Brief Psychiatric Symptom Rating Scale in clinical practice","volume":"89","author":"Lee","year":"1990","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/SAR.S15458","article-title":"To use or not to use: an update on licit and illicit ketamine use","volume":"2","author":"Li","year":"2011","journal-title":"J\u00a0Subst Abuse Rehab"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib14","first-page":"281","article-title":"Some methods for classification and analysis of multivariate observations","volume":"vol. 1","author":"MacQueen","year":"1967"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1360-0443.2006.01496.x","article-title":"The prevalence of psychotic symptoms among methamphetamine users","volume":"101","author":"McKetin","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-006-0572-3","article-title":"Acute and chronic effects of ketamine upon human memory: a review","volume":"188","author":"Morgan","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Independent Scientific Committee on Drugs. Ketamine use: a review","volume":"107","author":"Morgan","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Reports"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00000542-199704000-00021","article-title":"Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors","volume":"86","author":"Orser","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jpainsymman.2011.01.001","article-title":"Ketamine","volume":"41","author":"Quibell","year":"2011","journal-title":"J\u00a0Pain Symptom Manag"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib22","series-title":"Textbook of substance abuse treatment","article-title":"Clinical management: methamphetamine","author":"Rawson","year":"2008"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.comppsych.2008.07.009","article-title":"Prevalence of psychotic symptoms in substance users: a comparison across substances","volume":"50","author":"Smith","year":"2009","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145703003675","article-title":"Psychotic symptoms in methamphetamine psychotic in-patients","volume":"6","author":"Srisurapanont","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib26","series-title":"Patterns and trends of amphetamine-type stimulants and other drugs \u2013 Asia and the pacific","author":"United Nations Office on Drugs and Crime","year":"2012"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib27","series-title":"World Drug Report","doi-asserted-by":"crossref","DOI":"10.18356\/079beef9-en","author":"United Nations Office on Drugs and Crime","year":"2010"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.57.12.1139","article-title":"Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia","volume":"57","author":"Umbricht","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000542-198202000-00007","article-title":"Ketamine\u2014its pharmacology and therapeutic uses","volume":"56","author":"White","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib30","series-title":"Co-occurring addictive and psychotic disorders. Principals of Addiction Medicine","author":"Ziedonis","year":"2003"},{"key":"10.1016\/j.jpsychires.2014.02.010_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10550490490436055","article-title":"Psychiatric symptoms in methamphetamine users","volume":"13","author":"Zweben","year":"2004","journal-title":"Am J Addict"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395614000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395614000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:43:36Z","timestamp":1565217816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395614000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":31,"alternative-id":["S0022395614000508"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.02.010","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2014.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}